YTHDC2通过激活亡和NF-κB通路来促进败血症诱导的心肌病
Wei Wang1,2, Tie-Ning Zhang1, Zi-Mu Wang3
1Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
Virulence
|December 4, 2025
概括
一种RNA调节剂YTHDC2,通过增加心脏细胞死亡和激活NF-κB通路,促进败血症诱导的心肌病. 抑制YTHDC2为这种严重疾病提供了潜在的治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 败血症诱导心肌病 (SICM) 是败血症的一个关键并发症,需要新的治疗点.
- 在SICM中涉及N6-甲基氨酸 (m6A) RNA修饰,但m6A读者蛋白YTHDC2的作用尚不清楚.
研究的目的:
- 调查YTHDC2在败血症诱导心肌病变 (SICM) 病变发生中的作用.
- 探索YTHDC2作为SICM的潜在治疗点.
主要方法:
- 青少年大鼠和培养心肌细胞中的脂聚糖 (LPS) 诱导的SICM模型.
- RNA测序 (RNA-seq),西式涂抹,流细胞计,RNA免疫沉测序 (RIP-seq) 和RIP-qPCR.
- 使用腺相关病毒9 (AAV9) 进行心脏特异性抑制YTHDC2.
主要成果:
- 在LPS诱导的SICM模型中,YTHDC2被显著上调.
- YTHDC2促进心肌细胞亡,并激活NF-κB通路.
- YTHDC2直接与亲细胞亡蛋白 (BAX,BAK1) 和NF-κB子单元p65.5的mRNA结合.
- 心脏特异性抑制YTHDC2减弱的SICM相关的亡和NF-κB激活.
结论:
- YTHDC2是SICM病变发生的关键调节者,驱动心肌细胞亡和NF-κB信号传递.
- 向YTHDC2为败血症诱导的心肌病症提供了一个有希望的治疗策略.
更多相关视频
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.5K
08:22In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
3.4K
相关概念视频
The Extrinsic Apoptotic Pathway
8.0K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.0K
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
Myocarditis I: Introduction
343
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
343
Cardiomyopathy II: Dilated Cardiomyopathy
447
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
447
Caspases
13.6K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374
